ELITE PHARMACEUTICALS INC /NV/ Annual Operating Income (Loss) in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Elite Pharmaceuticals Inc /Nv/ quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
  • Elite Pharmaceuticals Inc /Nv/ Operating Income (Loss) for the quarter ending December 31, 2024 was $1.1M, a 68.9% decline year-over-year.
  • Elite Pharmaceuticals Inc /Nv/ Operating Income (Loss) for the twelve months ending December 31, 2024 was $12.2M, a 82.5% increase year-over-year.
  • Elite Pharmaceuticals Inc /Nv/ annual Operating Income (Loss) for 2023 was $10.8M, a 193% increase from 2022.
  • Elite Pharmaceuticals Inc /Nv/ annual Operating Income (Loss) for 2022 was $3.68M, a 27.5% decline from 2021.
  • Elite Pharmaceuticals Inc /Nv/ annual Operating Income (Loss) for 2021 was $5.07M, a 141% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $10.8M +$7.11M +193% Apr 1, 2023 Mar 31, 2024 10-K 2024-07-01
2022 $3.68M -$1.39M -27.5% Apr 1, 2022 Mar 31, 2023 10-K 2024-07-01
2021 $5.07M +$2.97M +141% Apr 1, 2021 Mar 31, 2022 10-K 2023-06-29
2020 $2.1M +$4.39M Apr 1, 2020 Mar 31, 2021 10-K 2022-06-29
2019 -$2.29M +$6.87M +75% Apr 1, 2019 Mar 31, 2020 10-K 2021-06-14
2018 -$9.16M -$107K -1.19% Apr 1, 2018 Mar 31, 2019 10-K 2020-06-30
2017 -$9.05M -$1.7M -23% Apr 1, 2017 Mar 31, 2018 10-K 2019-06-21
2016 -$7.36M +$961K +11.6% Apr 1, 2016 Mar 31, 2017 10-K 2018-06-14
2015 -$8.32M +$8.19M +49.6% Apr 1, 2015 Mar 31, 2016 10-K 2018-06-14
2014 -$16.5M -$11.2M -212% Apr 1, 2014 Mar 31, 2015 10-K 2017-06-14
2013 -$5.28M -$3.72M -238% Apr 1, 2013 Mar 31, 2014 10-K 2016-06-15
2012 -$1.56M +$403K +20.5% Apr 1, 2012 Mar 31, 2013 10-K 2014-06-30
2011 -$1.97M -$1.08M -122% Apr 1, 2011 Mar 31, 2012 10-K 2013-06-21
2010 -$886K Apr 1, 2010 Mar 31, 2011 10-K 2012-06-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.